A novel frameshift deletion in autosomal recessive SBF1-related syndromic neuropathy with necklace fibres

Objective To identify the genetic cause of complex neuropathy in two siblings from a consanguineous family. Methods The patients were recruited from our clinic. Muscle biopsy and whole-exome sequencing (WES) were performed. Fibroblasts cell lines from the index patient, unaffected parents, and three normal controls were used for cDNA analysis and western blot. Results The index patient was a 29-year-old male with clinical phenotype of syndactyly, pes cavus, swallowing difficulties, vision problem, imbalance, and muscle weakness. The sibling had similar, but milder symptoms. Nerve conduction studies and electromyography of both patients suggested sensory-motor axonal neuropathy. Muscle biopsy showed a feature of necklace fibres. WES identified a novel homozygous frameshift deletion (c.5477-5478del; p.1826-1826del) in exon 40 of the SBF1 gene in the two siblings, while both parents and the unaffected sibling were heterozygous carriers. Functional analysis showed a markedly reduced level of MTMR5 protein encoded by SBF1 in the index case. The levels of MTMR5 protein in unaffected parents were similar to those found in controls. Conclusion A novel homozygous frameshift deletion in SBF1 was identified in this family. Sensory-motor axonal neuropathy and necklace fibres in biopsy were the major features expanding the phenotypic spectrum of SBF1-related recessive syndromic neuropathy. Electronic supplementary material The online version of this article (10.1007/s00415-020-09827-y) contains supplementary material, which is available to authorized users.


Introduction
Charcot-Marie-Tooth (CMT) disease is a large group of clinically and genetically heterogeneous inherited neuropathies which are characterised by slowly progressive distal Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s0041 5-020-09827 -y) contains supplementary material, which is available to authorized users. muscle weakness, wasting, and sensory loss. Autosomal recessive forms of demyelinating CMT are also called CMT4 and a specific subgroup CMT4B is characterised by severe demyelinating neuropathy with focal myelin outfoldings and secondary axonal loss [1]. Mutations in genes encoding proteins of myotubularin family, namely MTMR2 (OMIM#603557) [2], MTMR13/SBF2 (OMIM#607697) [3], and MTMR5/SBF1 (OMIM#603560) [4], are associated with subtypes CMT4B1, CMT4B2, and CMT4B3, respectively. In addition to the pure neuropathic form of CMT4B3, mutations in SBF1 have also been reported in four families with severe syndromic manifestations such as sensory-motor polyneuropathy, multiple cranial nerve involvement, cognitive delay, and skeletal abnormalities [5][6][7]. In this study, a novel frameshift deletion in SBF1 was identified in two siblings with complex neuropathy and "necklace fibres" in muscle biopsy, expanding the spectrum of SBF1-related syndromic neuropathy.

Methods
The affected siblings from a British family (II-2 and II-1, Fig. 1a) were seen and examined by neurologists at the National Hospital for Neurology and Neurosurgery (NHNN), University College London (UCL). Muscle biopsy was performed on the index case (II-2). MRI scans were performed in both patients. Whole-exome sequencing was performed on the DNA from the index case (II-2). The data were processed through an in-house bioinformatics pipeline as described previously [8]. Fibroblasts cell lines obtained from skin biopsies from the index case, unaffected parents (I-1 and I-2), and three normal controls (C1-C3) were used for mRNA analysis and western blot.

Results
The index patient (II-2) and his affected sister (II-1) were from a consanguineous family where parents are second cousins (Fig. 1a). The patient II-2 was born with syndactyly of the third and fourth fingers of both hands and the second and third toes of both feet. He also had pes cavus of both feet ( Fig. 2d-f). He started walking by age of 1 1 / 2 , and his walking became clumsy at the age of three. By the age of four, he also had difficulty in pronouncing consonants. He was noted to display poor pencil grasp at the age of eight, and later received a diagnosis of dyspraxia with hypotonia. In addition, he had visual abnormalities with bilateral dilated pupils (unreactive to light) at the age of two, and had a history of photophobia dating back to the age of three. Over the years, the patient developed symptoms of slowness of swallowing, choking on food, blurred and double vision, imbalance, dragging his legs, easy fatigue, and weakness. These symptoms, particularly his gait, speech, and eyelid drop, were worse in the evening. The patient currently wears ankle foot to support his walking. On examination, he had obvious strabismus, gaze-evoked nystagmus to the left, as well as on up-gaze, and he had broken pursuit movements. He has a tonic pupil not reactive to light or accommodation.  2 Clinical features of the index patient and his sister. a-f and k-m were from the index patient II-2, and h-j were from the affected sister II-1. The tongue of the index patient was atrophic (b); muscle wasting in both calves (c); pes cavus and slim ankle as pointed by arrow in (d); syndactyly of two toes of both feet (e-f) as pointed by arrow, compared to a normal foot (g); abnormal colour of both feet of the affected sister (h-j); syndactyly of two fingers of both hands (k-m) pointed by a small arrow in compared to a normal hand on the right (k), a slim wrist pointed by an arrow in (k), and a surgery scar on left hand pointed by arrow in (m) His fundi were normal. The rest of cranial nerve examination was normal. Power in lower limbs was Grade 4/5 throughout. Distal weakness in wrist extension was at 4/5, and finger extension and flexion were at 3/5. He displayed symmetrical hypo-reflexia with bilateral extensor plantars; however, his coordination was normal. Sensory examination showed that he had a patchy pin-prick loss in a glove and stocking distribution. Blood tests were negative for acetylcholine receptor antibodies, anti-MUSK antibody, and anti-voltage gated calcium channel antibody. The creatine kinase level and metabolic testing were normal. Electromyography and nerve conduction study of both patients were performed, and showed moderately severe axonal sensory-motor neuropathy ( Table 1). There was no evidence of defect at the neuromuscular junction. There were mild chronic neurogenic changes on sampling the left orbicularis oculi. MRI of his head and whole spine showed mature damage in periaqueductal grey matter of upper tegmentum, and the prominence of the central canal at T7/8 level and the cord was mildly thinned throughout, but was otherwise normal (Fig. 4). Muscle biopsy showed marked neurogenic atrophy with prominent internal nuclei and appearance of necklace fibres (Fig. 3).
The elder sister (II-1) of the index patient also had similar pupils and disc appearance to the index patient, with slightly difficult walking, some weakness and wasting in her hands and feet, and endometriosis. On examination, her eyes showed slightly jerky pursuit movement. She had thin wrists and small hands but no clear wasting and only slight weakness of the thumbs. Her feet were similar to the hands, with only minimal weak dorsiflexion. She had similar sensory loss in a glove and stock distribution, and her feet also became discoloured, often black and quite cold. (Fig. 2h-j) She also showed similar changes in MRI of brain and spinal cord (Fig. 4).
Both of their parents and the younger brother were not affected. Overall, the phenotype in this family is consistent with an autosomal recessive form of inheritance.
During genetic analysis, we screened for nonsynonymous, splice-site and coding indel variants with a minor allele frequency (MAF) < 1% in the 1000 Genomes project, Exome Variant Server, and the Exome Aggregation Consortium (ExAC) databases. In the filtering steps, we also prioritised for homozygous or compound heterozygous variants in autosomal recessive genes. This left a novel homozygous frameshift deletion (c.5477-5478del; p.1826-1826del) in exon 40 of the SBF1/MTMR5 gene, a known gene for CMT. This deletion is absent in the above public databases. The variant were confirmed by Sanger sequencing. Segregation analysis in both parents and two siblings found that the affected sister (II-1) also harbours the same homozygous frameshift deletion, and both parents as well as the  Yes Yes Sensory-motor axonal neuropathy unaffected sibling are heterozygous carriers of the deletion in SBF1 (Fig. 1b). The deletion occurs in the last exon of SBF1 gene and causes a frameshift. This leads to a premature stop codon at 1850 amino acid position and produces a truncated protein by 43 amino acid residues. Western blot showed a markedly reduced level of MTMR5 protein in the patient with homozygous frameshift deletion compared with both heterozygous parents and controls. (Fig. 1c-e). There was a trend that the level of MTMR5 protein was lower in carriers than controls. This suggests that the homozygous frameshift deletion p.1826-1826del in SBF1 causes a marked decay of the protein level.

Discussion
Our family is the sixth family identified with mutations in SBF1 (Supplementary Table). They share several similar phenotypes with previously reported families with CMT4B3. Ophthalmoplegia was seen in most reported cases in addition to progressive weakness of the limbs and sensory-motor axonal neuropathy [5,9]. Development abnormalities were also common features, such as short stature, microcephaly, syndactyly, scoliosis, lumbar hyperlordosis, foot drop, pes cavus/planus, and gynecomastia. However, microcephaly and moderate-to-severe intellectual disability were observed in three previously described families [5,7,10], but not in the present family. The distinct "fork and bracket" sign at the pontine and mesencephalic level of brain MRI was reported in two previous families [7,10], while the MRI of our patients showed abnormality in the posterior area of the midbrain and spinal cord atrophy. Although the EMG suggested a feature of axonal sensorymotor neuropathy, the appearance of necklace fibres seen in muscle biopsy is an intriguing feature observed in our index patient, which was not observed in the previous SBF1related cases. Necklace fibres with nuclear internalisation have been reported as a histological hallmark of X-linked myotubular myopathy related to mutations in the phosphoinositide phosphatase myotubularin 1 (MTM1) gene and also a late-onset dynamin-2 (DNM2) gene-related centronuclear myopathy [11,12]. These fibres were usually described to be small and obliquely oriented with an increased density of mitochondria and sarcoplasmic reticulum profiles, and internal nuclei usually aligned like the necklace [13].
Neither MTM1 nor DNM2 was found in the index patient. Our study is the first to report necklace fibres in SBF1related phenotypes, which expands the clinical and molecular genetic spectrum of this specific pathological feature.
The SBF1 gene encodes protein MTMR5, a member of the myotubularin-related (MTMR) family. MTMR proteins are a large family of phosphoinositide (PI) 3-phosphatases which are involved in membrane trafficking and endocytosis [14]. The protein domain cores include GRAM domain (Glucosyltransferase, Rab-like GTPase Activator, and Myotubularins), RID (Rac-Induced recruitment Domain), PTP/DSP homology (tyrosine/dual-specificity phosphatase super-family), and SID (SET-interacting domain) [14]. Some members of the family contain a catalytically active PTP/ DSP domain, such as MTMR2 [14]. Some members contain catalytically inactive substitutions in the phosphatase domain, and thus, they belong to a subgroup called "pseudophosphatases", such as MTMR5 and MTM13 [14]. Studies suggested that MTMR5 and MTMR13 interact with MTMR2 directly via their coiled-coil domains increasing the phosphatase activity of MTMR2 as well as commanding its subcellular localization [14].
Loss of function of MTMR5 was suggested to cause a defect in the late stages of spermatogenesis in mice [15] and studies on humans showed that rare variants in SBF1 are linked to male infertility [16]. However, the pathophysiological pathways of MTMR5-induced neuropathy have not been fully elucidated. MTMR5 and MTMR13 are homologues which share 59% overall sequence identity. It has been suggested that loss of function of MTMR13, encoded by the SBF2 gene, leads to alterations in MTMR2 function and subsequent dysfunction of membrane trafficking, endocytic/ exocytic processes, and neuron-Schwann cell interactions [17]. MTMR13 -/-mice showed myelin outfoldings and infoldings in motor and sensory peripheral nerves as pathological hallmarks of CMT4B2 [18]. The level of MTMR2 was decreased by ~ 50% in MTMR13-/-sciatic nerves, suggesting that MTMR13 influences MTMR2 stability [18]. MTMR2 also plays a crucial role in axon development and maintenance by interacting with the neurofilament light chain [19]. This could be affected due to altered function of MTMR13.
As MTMR5 is the closest homologue of MTMR13, it is possible that the loss of function in MTMR5 could also induce dysfunction in neuronal or Schwann cells via a similar mechanism with the MTMR2/MTMR13 complex. This may explain the strikingly similar phenotypes of patients with recessive mutations in the MTMR2, SBF2, and SBF1 genes.
In the present study, the protein level of MTMR5 was markedly reduced due to the homozygous frameshift deletion in SBF1 identified in both affected siblings, indicating a loss-of-function mechanism underlying the pathogenesis of the disease. Whether this causes the patient to be infertile is as yet unknown.

Conclusion
We reported a novel homozygous frameshift deletion in SBF1 in a family affected with a rare form of neuropathy with necklace fibres on the muscle biopsy. Segregation and functional analysis suggested that the homozygous deletion in SBF1 was the main culprit to the disease via a loss-offunction mechanism. Our findings in this family expand the phenotypic spectrum of SBF1-related recessive syndromic neuropathy. Author contributions QG contributed to all the experimental work, data analysis, and drafting the first version of the paper. JLH contributed to the review and photography of the muscle biopsies. CL contributed to the generation of fibroblast cell lines from the patients and controls. VC, EO, and HH contributed to the examinations of the patients. All authors contributed to the revision of the manuscript.
Funding QG was supported by a University College London (UCL) Impact Studentship and a scholarship from the Chinese Scholarship Council, and is currently supported by the National Natural Science Foundation of China (81801243). CB was supported by the Wellcome Trust and is currently supported by the MSA Trust. MGH is supported by an MRC Centre Grant 2013-2018 (MR/K000608/01). We thank the patients and their families for participating in our study. This publication was supported by researchers at the UCL/UCLH NIHR Biomedical Research Centre (BRC).

Compliance with ethical standards
Conflicts of interest The authors declare that they have no conflict of interest.

Ethics approval
The study was approved by the National Research Ethics Service (NRES) Committee London-Queen Square (REC reference: 12/LO/1557).

Consent to participate
The patients and the family consented for the study.

Consent for publication Both patients consented for obtaining their pictures for research and publication purposes.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.